Azithromycin Pricing Report

Azithromycin Prices December 2023

The price of azithromycin in the USA for Q4 2023 was 122750 USD/MT (Azithromycin Dihydrate) US, FDA. It saw a decline due to diminished demand, with market participants prioritizing the destocking of old inventories. The overall growth in new orders remained minimum and the decline in international trade persisted.  

In China, the price of azithromycin witnessed a notable reduction, reaching reached 120000 USD/MT (Azithromycin Dihydrate) US, FDA, attributed to the decreased order inquiries from both domestic and international markets. The decline in the domestic market was because of the growing concerns about antibiotic resistance, especially the excessive utilization of azithromycin.

Germany saw a drop in azithromycin prices, reaching 122195 USD/MT (Azithromycin Dihydrate) US, FDA, in December owing to the decreased demand from the healthcare and pharmaceutical industries as well as the return of inflation and persistently high interest rates. Companies and individuals cut back on investments and spending due to the current economic climate, which decreased demand for azithromycin and thus drove down prices.

Azithromycin Price Trend, Market Analysis, and News

IMARC’s newly published report, titled Azithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data, offers an in-depth analysis of azithromycin pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing azithromycin price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Azithromycin Market Analysis

The global azithromycin market size reached US$ 7.4 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 11.9 Billion, at a projected CAGR of 5.50% during 2023-2032.

• The increasing prevalence of chronic obstructive pulmonary disease (COPD) among the masses due to long-term exposure to irritating chemicals or particulate matter, especially from cigarette smoke, is strengthening the market growth. Azithromycin helps in the management of COPD by reducing the frequency of exacerbations and alleviating symptoms. According to America Lung Association, COPD was the sixth leading cause of mortality overall and the fifth leading cause of disease-related death in 2021, with 138,825 deaths attributed to the condition. Notably, more women (72,727) than men (66,098) died from COPD, yet men showed a higher mortality rate from the disease, with 36.8 deaths per 100,000 compared to 31.5 deaths per 100,000 in women.
• The growing geriatric population that is more susceptible to numerous bacterial infections due to weakened immune systems is offering a favorable market outlook. Azithromycin is useful in treating respiratory, urinary, and skin infections among the older demographics. Additionally, its simple dosage schedule makes it easier for elderly patients to adhere to medication regimen. As per the World Health Organization (WHO), 1 in 6 people globally will be aged 60 years or older by 2050, with the population in this age group increasing from 1 billion in 2020 to 1.4 billion. Furthermore, the number of individuals aged 60 years and older is projected to double to 2.1 billion, while the population aged 80 years or older is anticipated to triple to reach 426 million by 2050.
• The rising emergence of antibiotic-resistant strains of bacteria is catalyzing the demand for azithromycin, which is effective against certain drug-resistant bacteria. Its favorable safety profile positions it as a valuable therapeutic option in combating antibiotic resistance. Based on the data provided by the World Bank,  antimicrobial resistance (AMR) could lead to an additional US$1 trillion in healthcare costs by 2050. Moreover, it could result in annual gross domestic product (GDP) losses ranging from US$1 trillion to US$3.4 trillion by 2030. These estimates highlight the urgent need for comprehensive strategies to address and mitigate the impact of AMR on both public health and global economies.
• The increasing incidence of bacterial infections, including respiratory tract infections, sexually transmitted diseases (STDs), and skin infections, is catalyzing the demand for azithromycin due to its effectiveness against various bacterial pathogens.

Azithromycin News

The report covers the latest developments, updates, and trends impacting the global azithromycin market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in azithromycin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the azithromycin industry:

• In April 2023: Zydus Lifesciences Limited obtained final approval from the United States Food and Drug Administration (USFDA) for the production and distribution of Azithromycin Tablets USP, 500 mg (USRLD: Zithromax Tablets).
• In January 2023: Poly Pharmaceutical Co., Ltd. achieved market approval from the Israeli Ministry of Health's Pharmacy Division for the sale of Azithromycin injection, marking eligibility for sales in the Israeli market. Prior approvals for Bivalirudin injection and Ganciclovir injection in January and July 2023 respectively, also contribute to Poly Pharmaceutical's expansion in Israel.
• In January 2023: Pfizer Inc. and the International Trachoma Initiative donated the one billionth Zithromax® (azithromycin) dose, supporting the trachoma elimination strategy of WHO. This milestone follows the commitment of Pfizer to extend its antibiotic donation program until 2030, aiding 18 countries in their efforts to combat trachoma.

Product Description

Azithromycin is an antibiotic belonging to the macrolide class, created to combat a wide range of bacterial infections. It is synthesized through a complex process of fermentation, followed by a series of chemical reactions that introduce a methyl-substituted nitrogen atom into the lactone ring of erythromycin A. It is available in multiple forms, including oral tablets, capsules, suspension, and an intravenous formulation, catering to various patient needs and preferences.

It is incorporated into personal care products owing to its antibacterial properties. It may be present in skincare products targeting acne or other bacterial skin conditions, providing both therapeutic and preservative effects. It is also utilized in the agriculture sector to combat bacterial infections in crops and plants.

Regional Coverage

The report provides a detailed analysis of the azithromycin market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends. 

Global Azithromycin Price

The report offers a holistic view of the global azithromycin pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Azithromycin Price

In the European region, azithromycin pricing was shaped by multiple factors. October saw a decline attributed to subdued user sentiments, elevated interest rates, and ample supply. However, inflation sharply dropped due to lower fuel prices and swift interest rate hikes, reducing market demand and prices. Prices rebounded in November with increased demand from pharmaceutical and healthcare sectors, heightened individual spending, and reduced inventories.

This analysis can be extended to include detailed azithromycin price information for a comprehensive list of countries.

North America Azithromycin Price

In the North American azithromycin market prices were influenced by inflation, interest rates, and geopolitical tensions, resulting in a bearish sentiment and price decline compared to the previous year. October saw notable price fluctuations due to subdued domestic demand and abundant inventories, leading to decreased prices. However, signs of inflation easing in November led to higher individual spending and increasing prices.

Specific data on azithromycin prices within the United States and Canada can also be provided.

Middle East and Africa Azithromycin Price

The report explores the azithromycin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on azithromycin prices for countries can also be provided.

Asia Pacific Azithromycin Price

In Q4 2023, the Asia Pacific azithromycin market experienced notable price fluctuations. October saw a downturn attributed to reduced demand and oversupply, particularly due to a manufacturing sector contraction. However, November showed improvement with increased supply, demand, and manufacturer optimism, leading to rising prices. Heightened inquiries from downstream industries, notably the healthcare sector during the winter season, contributed to the upward trend.

This analysis can be further extended to include detailed azithromycin prices for a comprehensive list of countries within the region.

Latin America Azithromycin Price

The analysis of azithromycin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of azithromycin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting azithromycin price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the azithromycin industry.